NCT01229943 2022-08-04Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 2 Completed150 enrolled 12 charts